Opus Genetics (IRD) Depreciation & Amortization - Total (2011 - 2014)
Opus Genetics (IRD) reported Depreciation & Amortization - Total of $3744.0 for Q3 2014, down 61.18% year-over-year from $9645.0 in Q3 2013, and down 61.12% quarter-over-quarter from $9630.0 in Q2 2014.
Opus Genetics (IRD) Depreciation & Amortization - Total (2011 - 2014) Analysis & Trends
Opus Genetics (IRD) has 4 years of Depreciation & Amortization - Total data on file, last reported at $3744.0 in Q3 2014.
- Depreciation & Amortization - Total for Q3 2014 came in at $3744.0, down 61.18% year-over-year; the trailing twelve-month figure through Jun 2015 was $3744.0 (down 89.95% YoY), and the FY2013 annual result was $37133.0, down 12.39% from the prior year.
- Depreciation & Amortization - Total slipped to $3744.0 in Q3 2014 per IRD's latest filing, from $9630.0 in the prior quarter.
- Over five years, Depreciation & Amortization - Total peaked at $10721.0 in Q1 2012 and troughed at $3744.0 in Q3 2014.
- A 4-year average of $9491.4 and a median of $9886.0 in 2011 frame the typical range for Depreciation & Amortization - Total.
- The sharpest annual moves came in 2012 and 2014: Depreciation & Amortization - Total rose 5.87% in 2012, then sank 61.18% in 2014.
- A 4-year view of Depreciation & Amortization - Total shows it stood at $10166.0 in 2011, then grew by 0.56% to $10223.0 in 2012, then decreased by 12.58% to $8937.0 in 2013, then plunged by 58.11% to $3744.0 in 2014.
- Business Quant data shows IRD's Depreciation & Amortization - Total at $3744.0 in Q3 2014, $9630.0 in Q2 2014, and $9044.0 in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Opus Genetics | 355.39 Mn | 295.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 3,744.00 |
| Jun 30, 2014 | 9,630.00 |
| Mar 31, 2014 | 9,044.00 |
| Dec 31, 2013 | 8,937.00 |
| Sep 30, 2013 | 9,645.00 |
| Jun 30, 2013 | 9,235.00 |
| Mar 31, 2013 | 9,316.00 |
| Dec 31, 2012 | 10,223.00 |
| Sep 30, 2012 | 10,721.00 |
| Jun 30, 2012 | 10,721.00 |
| Mar 31, 2012 | 10,721.00 |
| Dec 31, 2011 | 10,166.00 |
| Sep 30, 2011 | 10,127.00 |
| Jun 30, 2011 | 10,650.00 |